Cargando…
Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
BACKGROUND: Predictive factors of nivolumab treatment response in patients with gastric cancer (GC) remain unclear. METHODS: In this retrospective cohort study, tissue specimens of patients with unresectable or recurrent GC and prior or scheduled treatment with nivolumab as third-line or higher ther...
Autores principales: | Hagi, Takaomi, Kurokawa, Yukinori, Kawabata, Ryohei, Omori, Takeshi, Matsuyama, Jin, Fujitani, Kazumasa, Hirao, Motohiro, Akamaru, Yusuke, Takahashi, Tsuyoshi, Yamasaki, Makoto, Satoh, Taroh, Eguchi, Hidetoshi, Doki, Yuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492241/ https://www.ncbi.nlm.nih.gov/pubmed/32616848 http://dx.doi.org/10.1038/s41416-020-0975-7 |
Ejemplares similares
-
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
por: Sakai, Daisuke, et al.
Publicado: (2022) -
Anti-metastatic effect of methylprednisolone targeting vascular endothelial cells under surgical stress
por: Hagi, Takaomi, et al.
Publicado: (2021) -
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)
por: Matsuyama, Jin, et al.
Publicado: (2022) -
Nivolumab-induced interstitial lung disease in a patient with gastric cancer
por: Kimura, Akie, et al.
Publicado: (2019) -
Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery
por: Hagi, Takaomi, et al.
Publicado: (2022)